{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["6(Suppl )"],"submitter":["Rodriguez-Otero P"],"journal":["HemaSphere"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9011718"],"repository":["biostudies-literature"],"pubmed_title":["P19: BASELINE CORRELATES OF COMPLETE RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL, BB2121), A BCMA-DIRECTED CAR T CELL THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF THE KARMMA TRIAL"],"pmcid":["PMC9011718"],"pubmed_authors":["Rowe E","Munshi N","Shah N","Agarwal A","Finney O","Campbell T","Berdeja J","Martin N","San-Miguel J","Rodriguez-Otero P","Jagannath S"],"additional_accession":[]},"is_claimable":false,"name":"P19: BASELINE CORRELATES OF COMPLETE RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL, BB2121), A BCMA-DIRECTED CAR T CELL THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF THE KARMMA TRIAL","description":null,"dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Apr","modification":"2025-04-26T13:01:21.325Z","creation":"2025-04-06T14:07:14.303Z"},"accession":"S-EPMC9011718","cross_references":{}}